GIP
TRIB

Granite Investment Partners’s Trinity Biotech TRIB Stock Holding History

Granite Investment Partners’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,140
Closed -$2.26M – 317
2016
Q3 		$2.26M Buy
1,140
+68
+6% +$127K 0.17% 149
2016
Q2 		$1.82M Buy
1,072
+48
+5% +$81.2K 0.14% 160
2016
Q1 		$1.79M Buy
1,024
+69
+7% +$110K 0.16% 157
2015
Q4 		$1.69M Sell
955
-2,461
-72% -$4.36M 0.15% 153
2015
Q3 		$5.86M Buy
3,416
+727
+27% +$1.75M 0.56% 74
2015
Q2 		$7.28M Sell
2,689
-476
-15% -$1.24M 0.67% 44
2015
Q1 		$9.14M Buy
3,165
+1,442
+84% +$4M 0.79% 29
2014
Q4 		$4.53M Buy
1,723
+786
+84% +$2.03M 0.51% 56
2014
Q3 		$2.57M Buy
937
+304
+48% +$988K 0.35% 72
2014
Q2 		$2.19M Buy
633
+323
+104% +$1.15M 0.31% 82
2014
Q1 		$1.13M Sell
310
-47
-13% -$185K 0.18% 115
2013
Q4 		$1.35M Buy
357
+9
+3% +$32.4K 0.21% 114
2013
Q3 		$1.14M Sell
348
-4
-1% -$11.7K 0.18% 120
2013
Q2 		$889K Buy
+352
New +$876K 0.16% 121

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Granite Investment Partners's TRIB Position: Q4 2016 in Review

Granite Investment Partners sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 1,140 shares — an estimated $2.26M sold.

Granite Investment Partners first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $9.14M in Q1 2015. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Granite Investment Partners reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Granite Investment Partners sold 1,140 Trinity Biotech shares in Q4 2016, an estimated $2.26M.
  • Granite Investment Partners first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Granite Investment Partners's Trinity Biotech position peaked at $9.14M in Q1 2015.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Granite Investment Partners's 13F filing for Q4 2016, filed 1 Feb 2017.